Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Food and Drug Administration (FDA)

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

FDA Approves Auvi-Q with Lower Dose for Infants and Small Children

Kept in the Dark Regarding Allergens: The FDA Warned You, We...

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

'No Love' Nashoba Brook Bakery Owner Responds

FDA Has No Love for Nashoba Brook Bakery. Neither Do We

FDA to Reduce Hurdles for Complex Generic Drug Development

Industry Foundation Awards Grant for Study of Allergen Recalls

FDA Approves New Peanut Allergy Claim on Labels

FDA Warns Pfizer's Meridian over Handling of EpiPen Malfunctions

Your School On Our Map

Put Your School on the Map